Outcomes and patterns of infections in patients with underlying haematological malignancies admitted to intensive care.

@article{Jos2012OutcomesAP,
  title={Outcomes and patterns of infections in patients with underlying haematological malignancies admitted to intensive care.},
  author={Ricardo J. Jos{\'e} and Paul E. Pfeffer and Ian Mcdonald and Steve Shaw and Balkrishna Padate and Caroline Mcnamara and Christopher C. Kibbler and Banwari Agarwal},
  journal={British journal of anaesthesia},
  year={2012},
  volume={109 2},
  pages={
          291-2
        }
}
1 Wildervanck LS. Een geval van aandoening van Klippel–Feil gecombineerd met abducens paralyse, retractio bulbi en doofstomheid. Ned Tijdschr Geneeskd 1952; 96: 2752–5 2 Baum VC, O’Flaherty JE. Anesthesia for Genetic, Metabolic, and Dysmorphic Syndromes of Childhood (2nd Edn). Philadelphia, Lippincott Williams & Wilkins, 2007: 396 3 Gupte G, Mahajan P, Shreenivas VK, Kher A, Bharucha BA. Wildervanck syndrome (cervico-oculo-acoustic syndrome). J Postgrad Med 1992; 38: 180 4 Butler MG, Hayes GB… 
Cancer patients with community-acquired pneumonia treated in intensive care have poorer outcomes associated with increased illness severity and septic shock at admission to intensive care: a retrospective cohort study
TLDR
Cancer patients with CAP had an increased risk of death that was associated with increased illness severity and prevalence of septic shock at the time of ICU admission, suggesting there may be a delay in recognition for the need for intensive care support in these patients.
Haematological malignancy in the intensive care unit: microbiology results and mortality
TLDR
A registry‐based retrospective study of haematology patients admitted to the ICU to investigate the relation between neutropenia, microbiology results and outcome of these patients.

References

SHOWING 1-5 OF 5 REFERENCES
Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.
TLDR
'Traditional' variables such as neutropenia, transplantation status, and APACHE II score no longer appear to be predictive and Mechanical ventilation and ≥2 organ failures were independently associated with in-hospital mortality.
Cytomegalovirus infection in non-transplant patients with hematologic neoplasms: a case series.
TLDR
In an era of intensive immuno-chemotherapy, CMV infection may become a serious threat for hematology patients and Physicians dealing with hematological malignancies should be aware ofCMV infection, especially for patients receiving rituximab and steroids.
Outcome of respiratory failure in hematologic malignancy.
TLDR
Despite intensive management and adequate diagnosis, respiratory failure in patients with hematologic malignancy carries a high mortality, and records from 1976 to 1985 may help identify groups with a limited prognosis for long-term recovery.
Cytomegalovirus pneumonia in patients with lymphoma
Even when treated with antiviral therapy, cytomegalovirus pneumonia (CMVp) is associated with high morbidity and mortality in immunocompromised patients. CMVp has been rarely reported in patients
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT